Innoviva, Inc. revenue for the last year amounted to 358.71 M USD, the most of which — 358.71 M USD — came from its highest performing source at the moment, Respiratory Products, the year earlier bringing 310.46 M USD. The greatest contribution to the revenue figure was made by United States — last year it brought Innoviva, Inc. 358.71 M USD, and the year before that — 310.46 M USD.